Lemaitre Vascular (LMAT) Cash from Investing Activities (2010 - 2026)

Lemaitre Vascular (LMAT) has reported Cash from Investing Activities for 17 consecutive years, with -$13.1 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Cash from Investing Activities fell 203.73% year-over-year to -$13.1 million; the TTM figure through Mar 2026 stood at -$73.7 million (up 63.51% YoY), while the FY2025 annual figure was -$64.9 million, up 67.55% from the prior year.
• Cash from Investing Activities improved to -$13.1 million in Q1 2026 per LMAT's latest filing, from -$16.8 million in the prior quarter.
• Across five years, Cash from Investing Activities topped out at -$402000.0 in Q4 2022 and bottomed at -$173.9 million in Q4 2024.
• Historically, Cash from Investing Activities has averaged -$18.4 million across 5 years, with a median of -$9.6 million in 2023.
• Annual changes were most pronounced in 2022 — Cash from Investing Activities surged 94.45% — and 2024, when it sank 7590.93%.
• Lemaitre Vascular's Cash from Investing Activities stood at -$402000.0 in 2022, then sank by 462.44% to -$2.3 million in 2023, then tumbled by 7590.93% to -$173.9 million in 2024, then jumped by 90.32% to -$16.8 million in 2025, then advanced by 22.01% to -$13.1 million in 2026.
• Business Quant data shows LMAT's Cash from Investing Activities at -$13.1 million in Q1 2026, -$16.8 million in Q4 2025, and -$27.4 million in Q3 2025.